Rheumatoid arthritis

Clinical Outcomes of Patients Within the Rheumatoid Arthritis Care Pathway Cohort at a Tertiary Care Integrated Delivery Network: A Comparison to Usual Care

Arthritis Care Res (Hoboken)Published Retrospective cohort study

Main finding · Proportion of patients in CDAI-based remissionResult — go to the resultHR for achieving remission 1.53 95% CI 1.11–2.10

Authors' conclusion

Patients in our RA care pathway were more likely to achieve remission than those in usual care. PMPM RA costs were higher compared to usual care.

Study context

Population
Patients with rheumatoid arthritis (RA) at the Allegheny Health Network, a tertiary care integrated delivery network
Participants
817 vs 3,651
Exposure
RA care pathway vs usual care
  • RA care pathwayn = 817
  • Usual caren = 3,651reference
Outcome
Proportion of patients in CDAI-based remission
Follow-up
24 months
Methodological detailsclinical and insurance claims data, tertiary care integrated delivery network
  • Clinical and insurance claims data
  • Tertiary care integrated delivery network

Main finding

As reported in the abstract

HR for achieving remission

1.53

95% CI 1.11–2.10

P = 0.008

By group

RA care pathwayvs Usual care
HR for achieving remission 1.53 (95% CI 1.11–2.10); P = 0.008
On average, remission occurred days earlier than usual care
64

Observational data: associations, not effects.

Further findings

Time to remission

On average, remission occurred earlier with care pathway than usual care (days)
64

Remission or low disease activity; and newly diagnosed RA (subgroup)

Same trend observed

RA-related per-member per-month (PMPM) costs

Significantly higher in care pathway, primarily related to higher baseline clinical disease activity index (CDAI), comorbidities, and b/tsDMARD use and switching

Original publication

Clinical Outcomes of Patients Within the Rheumatoid Arthritis Care Pathway Cohort at a Tertiary Care Integrated Delivery Network: A Comparison to Usual Care. Arthritis Care Res (Hoboken). Published 16 December 2025. doi:10.1002/acr.25649

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.